• General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Article

EHRs benefit patients and doctors, CMS says

The adoption of electronic health records by physicians and hospitals is not only benefiting the patient, but the healthcare provider, too, according to new data from the Centers for Medicare & Medicaid Services (CMS).

 

The adoption of electronic health records by physicians and hospitals is not only benefiting the patient, but the healthcare provider, too, according to new data from the Centers for Medicare & Medicaid Services (CMS).

CMS reported July 17 that about 80 percent of eligible hospitals and more than 50 percent of eligible professionals who use EHRs have received incentive payments from Medicare or Medicaid, CMS reports in a press release. The payments are made possible through Medicare and Medcaid EHR incentive programs.

By using EHRs, patients have more access to their health records and the records can be easily and securely shared between healthcare providers.

“More patients than ever before are seeing the benefits of their providers using electronic health records to help better coordinate and manage their care,” said Farzad Mostashari, M.D., national coordinator for health information technology in the release. “These data show that health care professionals are not only adopting electronic health records rapidly, they’re also using them to improve care.”

To get weekly news and analysis for today's skincare specialists, subscribe to Dermatology Times eNews.

Related Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
© 2024 MJH Life Sciences

All rights reserved.